Charles Schwab Investment Management Inc Exagen Inc. Call Options Transaction History
Charles Schwab Investment Management Inc
- $429 Billion
- Q1 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding XGN
# of Institutions
35Shares Held
6.21MCall Options Held
1.6KPut Options Held
4.1K-
Rtw Investments, LP New York, NY1.5MShares$2.62 Million0.04% of portfolio
-
Cowen And Company, LLC899KShares$1.56 Million0.05% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT787KShares$1.37 Million0.01% of portfolio
-
Silvercrest Asset Management Group LLC New York, NY545KShares$948,0850.01% of portfolio
-
Perkins Capital Management Inc494KShares$858,8130.68% of portfolio
About EXAGEN INC.
- Ticker XGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 16,260,400
- Market Cap $28.3M
- Description
- Exagen Inc. develops and commercializes various testing products based on its cell-bound complement activation products technology under the AVISE brand in the United States. It enables rheumatologists to care for patients through the diagnosis, prognosis, and monitoring of autoimmune and autoimmune-related diseases, including systemic lupus ery...